A Critical Review of Properties and Analytical/Bioanalytical Methods for Characterization of Cetuximab-Reference-Cited by-同舟云学术

A Critical Review of Properties and Analytical/Bioanalytical Methods for Characterization of Cetuximab

Published:2019-03-14 Issue:2 Volume:50 Page:125-135
ISSN:1040-8347
Container-title:Critical Reviews in Analytical Chemistry
language:en
Short-container-title:Critical Reviews in Analytical Chemistry

Author:

Hanck-Silva Gilmar¹^ORCID,Fatori Trevizan Lucas Noboru¹^ORCID,Petrilli Raquel²,de Lima Felipe Tita¹^ORCID,Eloy Josimar O.³^ORCID,Chorilli Marlus¹^ORCID

Affiliation:

1. School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil;

2. School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil;

3. College of Pharmacy, Dentistry and Nursing, Federal University of Ceará (UFC), Fortaleza, Ceará, Brazil

Publisher

Informa UK Limited

Subject

Analytical Chemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/10408347.2019.1581984

Reference66 articles.

1. Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial

2. The Epidermal Growth Factor Receptor and Its Inhibition in Cancer Therapy

3. The EGFR as a target for anticancer therapy—focus on cetuximab

4. Cetuximab

5. Antibody-based therapeutics: Focus on prostate cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roadmap for Drug Product Development and Manufacturing of Biologics;Journal of Pharmaceutical Sciences;2024-02

2. Structural Insights into the Design of Synthetic Nanobody Libraries;Molecules;2022-03-28

3. EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges;Vaccines;2022-03-24

4. Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability;Antibodies;2022-01-13

5. Highlights in targeted nanoparticles as a delivery strategy for glioma treatment;International Journal of Pharmaceutics;2021-07